Abstract
The early diagnosis and aggressive treatment in patients diagnosed with a cancer led them to lead a life with a good survival rate. This in turn leads to increase in the number of second primary malignancies. Our article aims to report the prevalence and survival of both synchronous and metachronous second primary malignancies and challenges in treatment by reviewing our retrospective data. A hospital based gathering of retrospective data of the patients diagnosed with second primary malignancies over 9 years from January 2014 to June 2022. Patient details with regards to age, sex, distribution of primary sites, histopathology reports, synchronous or metachronous, treatment details are recorded (Patients fulfilling IARC Definition and Warren Gates criteria). A total of 86 patients were analysed in the retrospective data of whom females contribute the most — 74.4% (n = 64). Metachronous type of tumours — 68.6% (n = 59) are common than synchronous tumours. Overall, patients with breast cancer are more vulnerable for second primary malignancies accounting for 31% and second primary were prone to occur in the ovary followed by cervix. The median survival following first primary tumour diagnosis was 44 months and that of the second primary tumour was 11 months. With advanced screening procedures and evolving treatments, the incidence of second primary malignancies is steadily increasing and the outcomes are poorer since there are no proper set guidelines. More awareness, research and studies are needed to investigate in the treatment of second primary malignancies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
Owen LJ (1921) Multiple malignant neoplasms. JAMA 76:1329–1333
Buiatti E, Crocetti E, Acciai S et al (1997) Incidence of second primary cancers in three Italian population-based cancer registries. Eur J Cancer 33:1829–1834
Rosso S, De Angelis R, Ciccolallo L et al (2009) Multiple tumours in survival estimates. Eur J Cancer 45:1080–1094
Coyte A, Morrison DS, McLoone P (2014) Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study. BMC Cancer 14:272
Amer MH (2014) Multiple neoplasms, single primaries, and patient survival. Cancer Manag Res 6:119–134
Shah SA, Riaz U, Zahoor I et al (2013) Carcinoma multiplex. J Coll Physicians Surg Pak 23:290–292
Hayat MJ, Howlader N, Reichman ME et al (2007) Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist 12:20–37
Bajdik CD, Abanto ZU, Spinelli JJ et al (2006) Identifying related cancer types based on their incidence among people with multiple cancers. Emerg Themes Epidemiol 3:17
AIRTUM Working Group (2010) Italian Cancer figures, report 2010: cancer prevalence in Italy. patients living with cancer, long-term survivors and cured patients. Epidemiol Prev 34:1–188
Donin N, Filson C, Drakaki A et al (2016) Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer 122:3075–3086
Berrington de Gonzalez A, Curtis RE, Kry SF et al (2011) Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 12:353–360
Zheng X, Li X, Wang M, Shen J, Sisti G, He Z, Huang J, Li YM, Wu A (2020) Multidisciplinary Oncology Research Collaborative Group (MORCG) et al. second primary malignancies among cancer patients. Ann Transl Med 8(10):638
Sanchez De Cos Escuin J, Rodriguez Lopez DP, Delgado Utrabo I et al (2016) Disease recurrence and second tumors in long-term survivors of lung cancer. Arch Bronconeumol 52:183–188
Bhaskarla A, Tang PC, Mashtare T et al (2010) Analysis of second primary lung cancers in the SEER database. J Surg Res 162:1–6
Ricceri F, Fasanelli F, Giraudo MT et al (2015) Risk of second primary malignancies in women with breast cancer: results from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 137:940–948
Soerjomataram I, Coebergh JW (2009) Epidemiology of multiple primary cancers. Methods Mol Biol 471:85–105
Garber JE, Offit K (2005) Hereditary cancer predisposition syndromes. J Clin Oncol 23:276–292
Ishimori T, Patel PV, Wahl RL (2005) Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 46:752–757
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Devi J, S.U., T.D, B., Rao H, P.S. et al. Second Primary Malignancies — a Retrospective Analysis from a Regional Cancer Centre of South India. Indian J Surg Oncol (2023). https://doi.org/10.1007/s13193-023-01762-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13193-023-01762-4